| Company | Reagent | Link to information | Remarks |
|---|---|---|---|
| BioMedica Diagnostics | ACTICLOT C | Method: Clotting Activator: Derived from the venom of the viper agkistrodon contortrix | |
| Chromogenix | Coamatic Protein C | Method: Chromogenic Activator: Derived from the venom of the viper agkistrodon contortrix Interferences: No interference of heparin levels up tot 3 IU/ml | |
| Helena Biosciences | Protein C | Method: Chromogenic Activator: Derived from the venom of the viper agkistrodon contortrix | |
| Hyphen BioMed | Biophen Protein C LRT | Hyphen Biophen Protein C LRT | Method: Chromogenic Activator: Derived from the venom of the viper agkistrodon contortrix Interferences: No interference for heparin < 1 IU/mL, bilirubin < 60 mg/dL, hemoglobin < 500 mg/dL and intralipids concentration < 1000 mg/dL. Aprotinin or presence of anti-human Protein C antibodies may decrease the measured Protein C activity. |
| Hyphen BioMed | Biophen Protein C | Hyphen Biophen Protein C 5 | Method: Chromogenic Activator: Derived from the venom of the viper agkistrodon contortrix Interferences: No interference for heparin < 1 IU/mL, bilirubin < 60 mg/dL, hemoglobin < 500 mg/dL and intralipids concentration < 1000 mg/dL. Aprotinin or presence of anti-human Protein C antibodies may decrease the measured Protein C activity. |
| Hyphen BioMed | Hemoclot Protein C | Hyphen Hemoclot Protein C | Method: Clotting Activator: Derived from the venom of the viper agkistrodon contortrix Interferences: No interference for heparin < 1 IU/mL. Special caution should be taken for patients with known high levels of FVIII:C or with LA |
| Nordic Biomarker | MRX Protein C | Method: Chromogenic Activator: Protein C activator Interferences: No interference from heparin < 2 U/ml, bilirubin ≤20 mg/dL, haemoglobin ≤200 mg/dL, triglycerides ≤350 mg/dL | |
| Pentapharm | Protac | Protac | Method: Chromogenic and clotting Activator: Derived from the venom of the viper agkistrodon contortrix |
| Precision Biologic | Cryocheck Clot C | Precision Biologic Cryocheck Clot C | Method: Clotting Activator: Russell’s viper venom (RVV-X) Interferences: No interference of factor VIII:C activity levels < 600% and heterozygous factor VLeiden mutation |
| Renam | Reachrom protein C | Method: Chromogenic | |
| Roche | Protein C Chrom | Roche Protein C Chrom | Method: Chromogenic Activator: Snake venom |
| Siemens Healthineers | Berichrom Protein C | Siemens Berichrom Protein C | Method: Chromogenic Activator: Derived from the venom of the viper agkistrodon contortrix Interferences: False low protein C activity may be obtained in patients being treated with aprotinin |
| Siemens Healthineers | Protein C Reagent | Siemens Protein C Reagent | Method: Clotting Activator: Derived from the venom of the viper agkistrodon contortrix Interferences: False low protein C activity may be obtained in patients being treated with aprotinin. |
| Stago | STA_Stachrom Protein C | Stago STA Stacrom Protein C | Method: Chromogenic Activator: Derived from the venom of the viper agkistrodon contortrix Interferences: No interference from hemoglobin < |
| Stago | STA-Staclot Protein C | Stago STA-Staclot Protein C | Method: Clotting Activator: Derived from the venom of the viper agkistrodon contortrix Interferences: No interference from heparin < 1 U/ml, LA, factor VIII:C activity levels < 250%. Trombin inhibitors may interference |
| Stago, Tcoag | TriniCLOT Protein C II | Stago TriniCLOT Protein C II | Method: Clotting Activator: Derived from the venom of the viper agkistrodon contortrix |
| Technoclone | Technochrom Protein C | Technoclone Technochrom Protein C | Method: Chromogenic Activator: Derived from the venom of the viper agkistrodon contortrix Interferences: No interference from heparin < 2 U/ml |
| Technoclone | Technoclot Protein C | Technoclone Technoclot Protein C | Method: Clotting Activator: Derived from the venom of the viper agkistrodon contortrix |
| Werfen | HemosIL Proclot | Werfen HemosIL ProClot | Method: Clotting Activator: Derived from the venom of the viper agkistrodon contortrix Interferences: No interference from heparin (LMW) up to 0.7 U/mL, heparin (UF) up to 1.5 U/mL, hemoglobin < 200 mg/dL, bilirubin < 25 mg/dL and triglycerides < 600 mg/dL. |
| Werfen | HemosIL Protein C | Werfen HemosIL Protein C | Method: Chromogenic Activator: Derived from the venom of the viper agkistrodon contortrix Interferences: no interference from heparin (UF or LMW heparin) < 2 U/mL, |
